Mergers & Acquisitions

Thermion Completes Additional Acquisition of a 171MW Self-Supply Wind Project

Thermion Completes Additional Acquisition of a 171MW Self-Supply Wind Project PR Newswire MEXICO CITY, March 26, 2018 – The project will be constructed in the state of Tamaulipas, Mexico , and seeks to develop, build and operate one of the most important wind farm complexes in the Americas. – Construction of all plants is anticipated to commence between the fourth quarter of 2018 and the first quarter of 2019. – The strong commitment to sustainability is one of the great values of the Mexican company. […]

Stock Analysts

Here’s Why it is Apt to Hold Hawaiian Holdings (HA) for Now

Hawaiian Holdings, Inc .’s HA performance with respect to passenger revenues is encouraging. Notably, the company has raised guidance for first-quarter 2018 operating revenue per available seat mile (RASM) owing to better-than-expected passenger revenue performance in each of its geographies as well as higher cargo demand across the network. It now expects RASM to increase 3-5%, up from its previous prediction of a decline of 0.5% to a rise of 2.5%. […]

Stock Analysts

Canadian National (CNI) Dips to 52-Week Low: Here’s Why

Shares of Canadian National Railway Company CNI hit a 52-week low of $70.59 during the trading session on Mar 23, before retracing a bit to close at $70.71. The stock has underperformed its industry in a year, having declined 2.6% versus the industry’s 15.9% rally. Reasons Behind the Price Plunge Canadian National’s network congestion problems have caused service delays, leading to mass customer dissatisfaction. […]

Stock Analysts

Glaxo Drops Bid for Pfizer Unit, Shingrix Gains EU/Japan Nod

GlaxoSmithKline plc GSK has withdrawn from the race to buy Pfizer’s PFE Consumer Healthcare segment. Last October, Pfizer had said that it was exploring strategic alternatives for its Consumer Healthcare segment including a partial or a full separation through a spin-off, sale or other transaction. A decision regarding the same is expected to be made this year and it may ultimately opt to retain the business Glaxo’s chief executive officer, Emma Walmsley said that management is interested in deals that will improve the company’s returns and not “compromise on its priorities for capital allocation”. […]